Physician profile
John T Cox
NPI 1497782064
$2,261.06
in general payments reported to CMS, 2019-2025
8 companies · $2,080 in 2025
The $2,080 reported for 2025 was more than what 97% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.29 · 2020: $18.25 · 2021: $13.37 · 2022: $14.47 · 2023: $89.74 · 2024: $25.32 · 2025: $2,080.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,000 · Food and Beverage: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,000.00 |
| Food and Beverage | $194.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $2,000.00 | 2025 | Gardasil 9 |
| Sun Pharmaceutical Industries INC. | $89.74 | 2023 | Yonsa, Odomzo |
| Boston Scientific Corporation | $56.19 | 2025 | Watchman |
| Conmed Corporation | $48.75 | 2024-2025 | Conmed Generators, Conmed Hemostasis |
| Verastem, INC. | $20.29 | 2019 | |
| Baudax Bio INC. | $18.25 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $14.47 | 2022 | |
| Novartis Pharmaceuticals Corporation | $13.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.